B

네오크레마

311390KOSDAQ

65.8 / 100

Reference Date: 2026-09-08

Financial Score28.5 / 40
News Sentiment21.3 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 2.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Neocrema is a functional food ingredient company specializing in microbiome-based products, producing functional sugars and peptides that offer health benefits such as gut environment improvement and blood sugar suppression. Through its subsidiary BB&C, the company diversifies its portfolio with materials and healthcare products, while expanding its market by developing alternative sweeteners and researching skin microbiota. The company also holds international certifications like Halal and Kosher for global exports.

Number of Employees

70people

Average Salary

54.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
10.17Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.21Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
3.58Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
10.64Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲82.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲267.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -2.3% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 2,410Won52-week high 10,41052-week low 2,205
1-month return4.0Point

1m +2.55% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14